
|Videos|February 3, 2018
Dr. Yardley Offers Advice to Community Oncologists on Managing Patients
Author(s)Denise Yardley, MD
Denise Yardley, MD, Senior Investigator, Sarah Cannon Research Institute, offers advice to community oncologists on managing patients.
Advertisement
Denise Yardley, MD, Senior Investigator, Sarah Cannon Research Institute, offers advice to community oncologists on managing patients.
The management of patients is a continual moving target, and the challenge is staying in tune with the new developments, Yardley says. It is also important to counsel patients on the role of clinical trials, and offer them appropriate clinical trial opportunities.
There has been an explosion of new and novel drugs and targets as a result of patients and physicians communicating about clinical trial opportunities, Yardley says.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
2
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
3
Targeting HER2-Low Breast Cancer: the ARX788 Phase 2 Clinical Trial
4
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
5








































